| budesonide inhalation suspension / Generic mfg. |
| Completed | 3 | 900 | US | Budesonide, Pulmicort RESPULES, Pulmicort TURBUHALER | AstraZeneca | Asthma | 12/04 | 12/04 | | |
NCT00232648: Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial Asthma |
|
|
| Completed | 3 | 54 | Japan | Pulmicort (budesonide) Respules | AstraZeneca | Asthma | 11/06 | 11/06 | | |
NCT00855959: Study to Evaluate Efficacy and Safety of Pulmicort Respules in Japanese Adult Asthmatic Patients |
|
|
| Completed | 3 | 108 | Japan | Budesonide, Pulmicort, Pulmicort Turbuhaler | AstraZeneca | Asthma | 08/09 | 08/09 | | |
NCT00588406: Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room. |
|
|
| Completed | 3 | 95 | US | Budesonide, Pulmicort Respules, albuterol, proventil, proair, ventolin, salbutamol, Ipratropium bromide, Atrovent, Prednisone, deltasone | Northwell Health, AstraZeneca, Jacobi Medical Center, Nassau University Medical Center | Asthma | 12/09 | 12/09 | | |
MIST, NCT00675584: CARE Network Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers |
|
|
| Completed | 3 | 278 | US | Budesonide, Pulmicort Respules®, Placebo Budesonide, Placebo Pulmicort Respules® | Milton S. Hershey Medical Center, National Heart, Lung, and Blood Institute (NHLBI) | Asthma | 07/10 | 07/10 | | |
2019-002849-38: A clinical study to assess the safety, systemic exposure and efficacy of a liquid for inhalation of budesonide (AQ001S) to treat asthma. étude de la sécurité, de l’exposition systémique et de l’efficacité d’un liquide pour inhalation de budésonide dans le traitement de l’asthme |
|
|
| Not yet recruiting | 2/3 | 24 | Europe | Budesonide inhalation solution 0.125 mg/ml, Nebbud 0.25 mg/2 ml, AQ001S 0.125 mg/ml, Inhalation solution, Nebbud 0.25 mg/2 ml zawiesina do nebulizacji | Aquilon Pharmaceuticals, Walloon Region (SPW-EER) | asthma, asthma, Diseases [C] - Respiratory Tract Diseases [C08] | | | | |
